BT3.F - BioTime, Inc.

Frankfurt - Frankfurt Delayed Price. Currency in EUR
Currency in EUR

Valuation Measures

Market Cap (intraday) 5160.87M
Enterprise Value 3130.52M
Trailing P/E 2.35
Forward P/E 1N/A
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)30.85
Price/Book (mrq)0.95
Enterprise Value/Revenue 325.03
Enterprise Value/EBITDA 6-3.51

Trading Information

Stock Price History

Beta (3Y Monthly) 2.59
52-Week Change 3-46.07%
S&P500 52-Week Change 37.29%
52 Week High 32.4800
52 Week Low 30.7520
50-Day Moving Average 30.9238
200-Day Moving Average 31.0375

Share Statistics

Avg Vol (3 month) 3702
Avg Vol (10 day) 31.02k
Shares Outstanding 5126.96M
Float 107.59M
% Held by Insiders 1N/A
% Held by Institutions 1N/A
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 2N/A
Last Split Date 3N/A

Financial Highlights

Currency in USD.

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Mar 31, 2019


Profit Margin 1,090.47%
Operating Margin (ttm)-774.09%

Management Effectiveness

Return on Assets (ttm)-17.16%
Return on Equity (ttm)42.63%

Income Statement

Revenue (ttm)5.21M
Revenue Per Share (ttm)0.04
Quarterly Revenue Growth (yoy)32.40%
Gross Profit (ttm)4.69M
Net Income Avi to Common (ttm)56.87M
Diluted EPS (ttm)0.4430
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)27.1M
Total Cash Per Share (mrq)0.18
Total Debt (mrq)5.09M
Total Debt/Equity (mrq)3.16
Current Ratio (mrq)3.51
Book Value Per Share (mrq)1.09

Cash Flow Statement

Operating Cash Flow (ttm)-29.86M
Levered Free Cash Flow (ttm)-15.3M